Answers are grounded in this paper and cite their sources.
The best of both worlds: BODIPY-based imaging probes can be tracelessly transformed into hybrid PET/fluorescence imaging reagents by direct 19F/18F exchange without the need for redesign. This approach has the potential to accelerate not only the development of imaging agents, but perhaps also the screening of therapeutic molecules.
No takes yet. Share an insight, caveat, or question.
Hendricks et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: